[1]
Pratiwi, S. et al. 2026. The Relationship Between Programmed Death-Ligand 1 and Cancer Stem Cells in Ovarian Cancer: Implications for Immunotherapy. Asian Pacific Journal of Cancer Biology. 11, 4 (Oct. 2026), 1181–1190. DOI:https://doi.org/10.31557/APJCB.2026.11.4.1181.